Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9076724 | 0.85 | CES1 (0.38) | CES1PLA2G2CEPHX2 | |
| SCHEMBL16263363 | 0.84 | CES1 (0.36) | CES1PLA2G2CEPHX2 | |
| SCHEMBL11897853 | 0.82 | — | — | |
| SCHEMBL15823328 | 0.82 | CES1 (0.46) | CES1PLA2G2CCYP2C9TSHRCYP2C19 | |
| SCHEMBL31189821 | 0.79 | CES1 (0.36) | CES1 | |
| SCHEMBL11897850 | 0.79 | CES1 (0.36) | CES1 | |
| Hydrochloric Acid SCHEMBL18225042 | 0.79 | ODC1 (0.38) | CES1PLA2G2C | |
| SCHEMBL1591167 | 0.78 | CA1 (0.35) | CES1EPHX2 | |
| SCHEMBL9588443 | 0.78 | MEN1 (0.32) | EPHX2 | |
| SCHEMBL27793802 | 0.78 | CES1 (0.34) | CES1PLA2G2CEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9196903-B2 | Nonaqueous-electrolyte batteries and nonaqueous electrolytic solutions | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-11-24 | — | — | US | claimed |
| US-20130084493-A1 | NONAQUEOUS-ELECTROLYTE BATTERIES AND NONAQUEOUS ELECTROLYTIC SOLUTIONS | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-04-04 | — | — | US | claimed |
| US-20260081225-A1 | ELECTROLYTIC SOLUTION AND BATTERY | Guangzhou Tinci Materials Technology Co., Ltd (CN) | 2026-03-19 | — | — | US | disclosed |
| EP-4704208-A1 | ELECTROLYTE AND BATTERY | Guangzhou Tinci Materials Technology Co., Ltd (CN) | 2026-03-04 | — | — | EP | disclosed |
| US-12456760-B2 | Non-aqueous electrolyte solution for sodium ion secondary battery, and sodium ion secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-10-28 | — | — | US | disclosed |
| US-20250266502-A1 | LITHIUM-ION BATTERY ELECTROLYTIC SOLUTION, LITHIUM-ION BATTERY, AND METHOD FOR IMPROVING BATTERY PERFORMANCE | Guangzhou Tinci Materials Technology Co., Ltd (CN) | 2025-08-21 | — | — | US | disclosed |
| US-20250233206-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-07-17 | — | — | US | disclosed |
| US-12315883-B2 | Non-aqueous electrolyte solution and non-aqueous electrolyte secondary battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-05-27 | — | — | US | disclosed |
| US-12261265-B2 | Method for producing lithium fluorosulfonate, lithium fluorosulfonate, nonaqueous electrolytic solution, and nonaqueous electrolytic solution secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-03-25 | — | — | US | disclosed |
| EP-3709426-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ENERGY DEVICE USING SAME | MITSUBISHI CHEM CORP (JP) | 2025-02-26 | — | — | EP | disclosed |
| WO-2024254996-A1 | ELECTROLYTE AND BATTERY | 广州天赐高新材料股份有限公司 | 2024-12-19 | — | — | WO | disclosed |
| US-20130071731-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-03-21 | — | — | US | disclosed |
| US-20130071730-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-03-21 | — | — | US | disclosed |
| EP-2571089-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION, AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2013-03-20 | — | — | EP | disclosed |
| EP-2571090-A1 | NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2013-03-20 | — | — | EP | disclosed |
| US-20120244425-A1 | NONAQUEOUS-ELECTROLYTE BATTERIES AND NONAQUEOUS ELECTROLYTIC SOLUTIONS | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-09-27 | — | — | US | disclosed |
| EP-2485316-A1 | NONAQUEOUS ELECTROLYTE BATTERY AND NONAQUEOUS ELECTROLYTE SOLUTION | Mitsubishi Chemical Corporation (JP) | 2012-08-08 | — | — | EP | disclosed |
| US-8173270-B2 | Conducting polymer composition and organic optoelectronic device employing the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2012-05-08 | — | — | US | disclosed |
| CN-101663790-A | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery using same | MITSUBISHI CHEM CORP | 2010-03-03 | — | — | CN | disclosed |
| US-5024694-A | Pre and postemergence herbicides | BAYER AKTIENGESELLSCHAFT (DE) | 1991-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260081225-A1 | ELECTROLYTIC SOLUTION AND BATTERY | HCN1, HCN2, HCN3 | CES1 2875/4885PLA2G2C 1094/4885CYP2C9 2945/4885 |
| US-12456760-B2 | Non-aqueous electrolyte solution for sodium ion secondary battery, and sodium ion secondary battery | NHERF1, NAP1L1, NAF1 | CES1 2113/4885PLA2G2C 271/4885CYP2C9 2089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.